Literature DB >> 12866040

Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.

James R Cerhan1, Kristin E Anderson, Carol A Janney, Celine M Vachon, Thomas E Witzig, Thomas M Habermann.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, seem to have chemopreventive properties against several types of cancer, particularly colon cancer. Persons with rheumatoid arthritis, an autoimmune disease for which NSAIDs are used commonly, have been reported to be at lower risk of colon cancer but at elevated risk of non-Hodgkin lymphoma (NHL), raising the possibility that NSAIDs may be a risk factor for NHL. We evaluated the association of use of NSAIDs, arthritis history, and risk of NHL in a prospective cohort of 27,290 postmenopausal women from the state of Iowa. The frequency of use of aspirin and of other NSAIDs excluding aspirin (e.g., ibuprofen), as well as a physician diagnosis of rheumatoid arthritis (RA) or osteoarthritis (OA), were self-reported on a questionnaire mailed in 1992. The incidence of NHL was ascertained through annual linkages to the Iowa SEER Cancer Registry. Relative risks (RR) and 95% confidence intervals (CI) were estimated using Cox proportional hazards regression. Through 7 years of follow-up, 131 cases of NHL were identified. Compared to women who did not use either aspirin or other non-aspirin NSAIDs, women using aspirin exclusively (RR = 1.71; 95% CI = 0.94-3.13), non-aspirin NSAIDs exclusively (RR = 2.39; 95% CI = 1.18-4.83), or both types of drugs (RR = 1.97; 95% CI = 1.06-3.68) were at increased risk of NHL. A diagnosis of RA (RR = 1.75; 95% CI = 1.09-2.79), but not OA (RR = 1.06; 95% CI = 0.67-1.68), was associated with risk of NHL, but the positive association of use of aspirin and other NSAIDs with NHL was independent of RA history. Multivariate adjustment for other NHL risk factors only attenuated slightly these associations, whereas exclusion of cases occurring during the first 2 years of follow-up strengthened the associations. These data suggest that use of NSAIDs, either aspirin or other non-aspirin NSAIDs, are associated positively with risk of NHL, and that this association is independent of RA history. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12866040     DOI: 10.1002/ijc.11311

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

Review 1.  Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.

Authors:  M P Bernard; S Bancos; P J Sime; R P Phipps
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

2.  Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort.

Authors:  Theodore M Brasky; John D Potter; Alan R Kristal; Ruth E Patterson; Ulrike Peters; Maryam M Asgari; Mark D Thornquist; Emily White
Journal:  Cancer Causes Control       Date:  2012-01-03       Impact factor: 2.506

3.  [Rationale for bone marrow examination in patients with inflammatory rheumatic diseases].

Authors:  Jutta G Richter; Pascal Gossen; Ulrich Germing; Sabine Blum; Barbara Hildebrandt; Stefan Braunstein; Dörte Huscher; Matthias Schneider
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.

Authors:  J Askling; L Klareskog; H Hjalgrim; E Baecklund; M Björkholm; A Ekbom
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

5.  Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) study.

Authors:  Roland B Walter; Filippo Milano; Theodore M Brasky; Emily White
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

6.  Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort.

Authors:  Eva Erber; Unhee Lim; Gertraud Maskarinec; Laurence N Kolonel
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

7.  Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women's Health Study.

Authors:  Lisa E Vaughan; Anna Prizment; Cindy K Blair; William Thomas; Kristin E Anderson
Journal:  Cancer Causes Control       Date:  2016-09-27       Impact factor: 2.506

8.  Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.

Authors:  Yan Qiao; Tingting Yang; Yong Gan; Wenzhen Li; Chao Wang; Yanhong Gong; Zuxun Lu
Journal:  BMC Cancer       Date:  2018-03-13       Impact factor: 4.430

9.  Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update.

Authors:  Bryan A Bassig; Qing Lan; Nathaniel Rothman; Yawei Zhang; Tongzhang Zheng
Journal:  J Cancer Epidemiol       Date:  2012-09-12

Review 10.  Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.

Authors:  Hui Yu; Liangbin Lin; Zhiqiang Zhang; Huiyuan Zhang; Hongbo Hu
Journal:  Signal Transduct Target Ther       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.